Empresa Synthetic Biologics Inc Nyse
Acciones
US87164U1025
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 62 | 01/06/15 | |
Michael Kaleko
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/12 |
- | - | ||
T. J. Swope
SEC | Corporate Secretary | - | - |
Manel Cascalló
PRN | Corporate Officer/Principal | - | 23/03/22 |
Vince Wacher
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jeff Wolf
BRD | Director/Board Member | 60 | 01/01/06 |
John Monahan
BRD | Director/Board Member | 77 | 11/11/20 |
Jeffrey Kraws
CHM | Chairman | 59 | 01/01/06 |
Chief Executive Officer | 62 | 01/06/15 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 17 868 282 | 16 946 072 ( 94,84 %) | 720 233 ( 4,031 %) | 94,84 % |
Información de la empresa
Theriva Biologics, Inc.
9605 Medical Center Drive Suite 270
20850, Rockville
+301 417 4364
http://www.therivabio.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+3,91 % | 109 mil M | |
+10,87 % | 105 mil M | |
+1,28 % | 22,25 mil M | |
-13,14 % | 22,09 mil M | |
-7,05 % | 18,68 mil M | |
-38,36 % | 17,58 mil M | |
-10,66 % | 16,85 mil M | |
+3,75 % | 13,76 mil M | |
+36,70 % | 12,46 mil M |